Fda novel drug approvals 2017 netarsudil rhopressa approval date?

When was Rhopressa (netarsudil) approved by the FDA in 2017?

Rhopressa (netarsudil ophthalmic solution 0.02%) received FDA approval in 2017. The approval date was December 18, 2017.

Was Rhopressa the first-in-class FDA approval for netarsudil in 2017?

Yes. FDA’s 2017 approval of Rhopressa (netarsudil) is tied to the drug’s initial marketing authorization for ophthalmic use (under the FDA’s new drug approval process for that product).

What condition was Rhopressa approved to treat?

Rhopressa is an ophthalmic medication approved for use in patients with elevated intraocular pressure (IOP) associated with glaucoma or ocular hypertension.

Sources

1. https://www.drugs.com/history/rhopressa.html